Objective To assess associations between breastfeeding and iron status at 9 months of age in 2 samples of Chinese infants.
I
ron deficiency is among the most common single nutrient deficiencies in the world, affecting women and young children disproportionately. 1 Iron deficiency is the most common cause of anemia. Both iron deficiency and iron deficiency anemia (IDA) in early life are associated with poorer cognitive, motor, and socialemotional development as well as neurophysiologic alterations. 2 The risk for developing iron deficiency in infancy increases with factors such as male sex, rapid growth, economic stress, and other family disadvantages. 3 Evidence is accumulating that breastfeeding into the second one-half year of life in otherwise healthy infants may be another risk factor. In the US, infants breastfed for 6 months or more were reported to be at higher risk of iron deficiency than infants who were not. 4 Other studies worldwide [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] reported associations between poorer iron status and breastfeeding into the second one-half year of postnatal life and beyond. A study in Bangladesh, 17 however, did not find an association between breastfeeding and anemia at 6 months of age. Studies restricted to breastfed infants alone do not address the question, but show the wide range in prevalence of iron deficiency or IDA in breastfed infants in different settings. [18] [19] [20] [21] It is important to ascertain associations between iron deficiency and breastfeeding over 6 months in different contexts. The World Health Organization (WHO) 
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recommends continuation of breastfeeding for up to 2 years of age or beyond, in addition to nutritionally adequate and safe complementary foods. The 6-to 24-month age period coincides with the maximal risk of iron deficiency, because iron requirements during the second one-half year of life are greater than at any other time of life. 22 However, there is debate about the iron needs of breastfed infants 4, 23, 24 and the risks of giving iron to iron-sufficient infants. 23, 25 The purpose of this secondary analysis was to determine associations between breastfeeding at 9 months of age and iron status in 2 cohorts of healthy Chinese infants.
Methods
This secondary analysis of an observational study involved Chinese infants with data on iron status and feeding at 9 months of age, obtained in the course of 2 studies on neurodevelopmental effects of iron deficiency in early life (ClinicalTrials.gov: NCT00642863 and NCT00613717). For the cohort in Zhejiang province in southeastern China, 142 of 204 infants with feeding data at 9 months had classifiable iron status; they constitute about 12% of 1196 infants screened for study participation at birth. For the cohort in Hebei province in northeastern China, 813 of 927 infants with feeding data at 9 months of age had classifiable iron status; they constitute about 54% of 1512 infants considered at birth. Signed informed consent was obtained from parents. Studies were approved by the Institutional Review Boards of the University of Michigan and Zhejiang University School of Medicine (Zhejiang cohort) or Peking University First Hospital (Hebei cohort). A program of multimicronutrient fortification that was being rolled out in some regions of China at the time 26 did not involve the areas where our participants lived.
In Zhejiang, mother-neonate pairs in Fuyang County were enrolled between December 2008 and November 2011. Pregnant women with normal, uncomplicated pregnancies were invited to participate after random screening at routine prenatal visits at 36-37 weeks' gestation. After birth, inclusion criteria were confirmed as previously reported. 27 Infants with cord hemoglobin (Hb) 2 SD below the mean for term infants (<130 g/L) 28 were provided iron supplements on ethical grounds (~1 mg/kg per day iron as liquid iron protein succynilate from 6 weeks to 9 months). Infants were assigned randomly to receive the same supplement or placebo from 6 weeks to 9 months of age if they had marginally low cord Hb (130-140 g/L) or cord serum ferritin < 60 mg/L (<5th percentile in our previous study in the same province 29 ). Other infants did not receive iron. For the Hebei cohort, infants in Sanhe County were invited to participate in a randomized, controlled trial of iron supplementation 30 if their mothers had participated in a Peking University First Hospital randomized, controlled trial of iron supplementation in pregnancy. 31 Enrollment in the infancy study occurred between December 2009 and June 2012. Inclusion/exclusion criteria for mothers have been previously published. 30, 31 Infants with very low cord serum ferritin (<35 mg/L) were provided iron supplements (~1 mg/kg per day iron as oral iron protein succynilate from 6 weeks to 9 months of age) and not randomized. They were included in the current analysis if they had data on feeding. Other infants were assigned randomly to the same iron supplement or placebo. 30 Background characteristics of the Zhejiang and Hebei cohorts are shown in Table I .
In each cohort, project personnel obtained information on feeding from mothers at a 9-month developmental assessment. We grouped infants based on feeding at 9 months of age. The breastfed group consisted of infants receiving breast milk as the sole source of milk. The mixed-fed group included those receiving some human milk and some formula. The formulafed group consisted of those receiving formula as the sole source of feeding. Formula in both settings was typically commercially prepared and iron fortified. Because data on consumption of juice and solids were not complete, we could not determine exclusive breastfeeding as defined by WHO. 33 However, complementary feeding of nutrient-containing solids and liquids besides breast milk typically starts at or around 4-6 months of age in China. 34 Iron status at 9 months of age was determined from venous blood samples in Zhejiang and capillary samples in Hebei. The measures of iron status included Hb, serum ferritin, serum transferrin receptor (sTfR), and zinc protoporphyrin/heme (ZPP/H). Serum C-reactive protein was also analyzed in Hebei. Laboratories maintained standard quality control procedures; methods have been previously published for both cohorts. 27, 30 Body iron was calculated using serum ferritin and sTfR according to the formula in Cook et al 35 : Body iron (mg/ kg) = -[log10(sTfR × 1000/ferritin) -2.8229]/0.1207. This formula used a sTfR assay described in Flowers et al. 36 The Beckman Coulter sTfR concentrations in the Hebei project required conversion for use in the formula. To do so, we built on published data for Flowers, Ramco, and Beckman Coulter sTfRs. As reported in Pfeiffer et al, 37 the Ramco assay was similar to Flowers et al. Ramco and Beckman Coulter assays (Beckman Coulter, Inc, Brea, California) were part of a WHO study that used a standard reference reagent for sTfR. 38 The Ramco assay (Ramco Laboratories, Inc, Stafford, Texas) yielded sTfR concentrations 4.3 times higher than Beckman Coulter, so the Flowers sTfR equivalent was calculated by the following formula: Flowers sTfR = 4.3 × Beckman Coulter sTfR. The assay used in Zhejiang did not require conversion.
Body iron ≥ 0 mg/kg indicates iron surplus in stores; body iron < 0 mg/kg indicates iron deficit in tissues. 39 Iron deficiency at 9 months of age was defined as body iron < 0 mg/kg. 39 IDA was defined as iron deficiency and anemia (Hb < 110 g/L per WHO guidelines 1 ) and iron sufficiency as body iron ≥ 0 mg/ kg and no anemia. As previously reported, 30, 31 we considered fetal-neonatal iron deficiency as cord serum ferritin < 75 mg/L or ZPP/H > 118 mmol/mol. The serum ferritin cutoff has been used in studies of neurodevelopmental effects; [40] [41] [42] the ZPP/H cutoff is the US 90th percentile. cal data to describe and compare cohorts. Associations between feeding pattern and iron status were analyzed separately for each cohort using c 2 and logistic regression. A single unified analysis was not appropriate owing to differences in study design, the prevalence of iron deficiency, and background characteristics. Separate analyses could also make results more generalizable if findings were similar in the different contexts.
We conducted univariate logistic regression to determine associations at 9 months of age between the predictor (feeding group) and the dependent variable (iron status group) in each cohort. Infants with anemia (Hb < 110 g/L) 1 who did not meet criteria for iron deficiency were excluded because their iron status could not be categorized-62 in Zhejiang and 114 in Hebei-leaving final inclusion of 142 and 813 infants, respectively. Multiple logistic regression modeling was used to adjust for clinically relevant, potentially important covariables (sex, age at testing, birth weight, gestational age, parental education, weight gain from birth to 9 months of age, iron supplementation in infancy, fetal-neonatal iron deficiency, and inflammation as measured by C-reactive protein [available for Hebei but not Zhejiang]). Covariates were included and then removed if they were not at least marginally significant (P < .10) until the most parsimonious model remained.
Results
Sample characteristics are shown in Table I . In both cohorts, there were slightly more males than females, infants were born at term with mean birth weights of >3 kg, and continued to grow well. The cohorts differed in most other background characteristics (Table I) . Infants in the Hebei cohort had lower length-for-age z-scores but higher weight-for-length z-scores at 9 months of age, meaning that, on average, they were shorter and heavier than infants in the Zhejiang cohort. A greater percentage of families in the Hebei cohort than the Zhejiang cohort were low income and parents were less educated. A higher proportion of Hebei cohort infants had iron deficiency or IDA at 9 months of age.
Zhejiang Cohort
At 9 months of age, feeding pattern was strongly associated with iron status (overall P < .001; Figure) . Because no formulafed infants had IDA, we combined iron deficiency and IDA in further analyses. Breastfed and mixed-fed groups differed significantly in iron deficiency/IDA from the formula-fed group (P = .001 and .04), but breastfed and mixed-fed groups did not (P = .12). Nearly one-third of infants in the breastfed group (31.4%) had iron deficiency/IDA. The odds of iron deficiency/ IDA were increased in both the breastfed and the mixed-fed groups compared with the formula-fed group (Table II) . No other variables were significant in the model.
Hebei Cohort
Feeding pattern was also strongly associated with iron status at 9 months of age in the Hebei cohort (overall P < .001; Figure) . Forty-four percent of infants in the breastfed group had IDA and 27.5% had iron deficiency. The breastfed, 32 §The prevalence of anemia in the Hebei sample for women who were not randomly assigned to receive prenatal iron supplementation. Including women who received iron supplementation in pregnancy, the prevalence of maternal anemia in Hebei was 17.9% (143/801). ¶Fetal-neonatal iron deficiency was defined as cord blood ZPP/H > 118 mmol/mol heme or serum ferritin < 75 ng/mL. 
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Volume 181 mixed-fed, and formula-fed groups differed significantly in iron status (P < .001). The odds of IDA were significantly increased in both the breastfed and mixed-fed groups compared with the formula-fed group (Table II) . Male sex, fetalneonatal iron deficiency, lower birth weight, higher weight gain from birth to 9 months of age, and younger age at testing remained as significant covariables. For iron deficiency, the odds were also increased in both the breastfed and mixed-fed groups compared with the formula-fed group (Table II) ; male sex and lower C-reactive protein were significant covariables.
Discussion
A high percentage of infants who were breastfed had IDA at 9 months of age in 2 separate Chinese cohorts. The relation between breastfeeding as the sole source of milk and iron deficiency/IDA at 9 months of age was similar in both the Hebei and the Zhejiang cohorts despite differences in background characteristics. These findings in 2 distinct regions of China mirror those in other studies, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] indicating that breastfeeding beyond 6 months of age is associated with poor iron status in a wide range of settings.
We identified 13 studies that examined the associations between breastfeeding for 6 months or more and infant iron status. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] In all but 4 studies, 5, 7, 11, 16 iron status was assessed only by Hb or Hb in combination with serum ferritin. Our panel of iron status measures was more comprehensive, particularly in its inclusion of sTfR, which allowed body iron to be calculated. The US Centers for Disease Control and Prevention included body iron < 0 mg/kg as a way to define iron deficiency in recent National Health and Nutrition Examination Surveys, 39 because body iron captures both iron storage and function in a single index and does not depend on specific cutoffs for individual iron status measures. Nonetheless, body iron may be a conservative indicator of iron deficiency in infancy, because other iron measures, such as ZPP/H or reticulocyte Hb, may indicate iron insufficiency before serum ferritin or sTfR are altered enough to make the body iron 
Figure.
Percentage of 9-month-old infants with IDA, iron deficiency, and iron sufficiency by feeding pattern in the Zhejiang (n = 142) and Hebei (n = 813) cohorts. The overall difference in iron status by feeding groups was significant in each cohort: Zhejiang, c 2 = 26.5, P < .001; Hebei, c 2 = 202.5, P < .001.
calculation < 0 mg/kg. We could not consider these options, however, because ZPP/H data were missing for about onethird of the Hebei cohort, and the hospitals were not set up to measure reticulocyte Hb. The infants in our study were relatively heavy and growing rapidly, as evidenced by birth weight, weight gain, and z-scores. Their rapid growth could explain the limited ability of breastfeeding to protect against IDA. Although the benefits of breastfeeding are indisputable, rapid growth of infants in many settings may now exceed the capacity of breast milk to meet iron needs. However, the ability to consider the importance of growth in most previous studies is limited. Four studies did not report birth weight or growth rate [9] [10] [11] 16 and 4 others reported birth weight only. 4, 7, 8, 13 Nonetheless, it is likely that birth weights and growth rates are higher now than in most of human history. 44 That infants in Hebei were shorter and heavier at 9 months of age than infants in Zhejiang raises the question of other micronutrient deficiencies or other factors.
The observational nature of our study means that it cannot establish a causal relation between breastfeeding and iron deficiency/IDA. It is not ethical to randomize women to breastfeeding or for different durations. Therefore, making a causal connection must rely on the robustness of the relation in the face of different contexts, populations, study designs, and definitions of breastfeeding and iron status. Careful statistical control of potential confounding factors is also critical. Our study adds to the literature in these respects. Biological plausibility is another consideration. A new study by Cai et al 45 provides an explanation for the low iron content of breast milk and the limited capacity of breast milk to meet infant iron needs. The study found that human mammary epithelial cells do not have the only known membrane iron transporter and thus apparently have no way to secrete iron into breast milk.
The clinical challenge is to how best to prevent iron deficiency/IDA in breastfed infants globally. In our cohorts, some infants received supplemental iron in the form of drops from 6 weeks to 9 months of age. As reported previously for the Hebei study, 30 there was limited hematologic response to iron supplementation, likely owing to insufficient supplement intake and rapid growth. Further studies with carefully supervised early iron supplementation are warranted. Home fortification is another promising approach for breastfed infants. Adding to the growing body of literature, a recent study of China's home fortification program showed its effectiveness in reducing anemia in 6-to 23-month-old children. 26 An unanswered question is whether starting at 6 months is too late to protect the developing brain from the effects of iron deficiency. In an editorial accompanying the Cai et al paper, Friel 46 challenges the rationale for exclusive breastfeeding for 6 months and argues cogently for providing external sources of iron earlier in life.
Our study has several further limitations. The analysis was cross-sectional. Feeding information was based on maternal report collected when infants were 9 months of age. The duration of exclusive breastfeeding, defined by the WHO, was not known. Incomplete data on complementary foods means that we cannot determine if groups within each cohort differed in other facets of feeding or the quality of the diet. We also cannot compare diet across cohorts. The use of venous blood in Zhejiang and capillary blood in Hebei may affect iron status differences across cohorts. ZPP/H was missing for part of the Zhejiang cohort, and we were able to adjust for C-reactive protein in the Hebei cohort only.
Despite limitations in the available studies, including ours, the accumulating evidence has global clinical implications. Specifically, breastfed infants in many settings worldwide warrant additional and earlier monitoring to prevent them from developing iron deficiency or IDA and to detect and treat iron deficiency/IDA before it becomes chronic and severe. Although more research is needed to determine the optimal timing, vehicle, and amount of iron supplementation, clinicians need updated protocols to guide their care of the infant who is breastfed. ■
